- Home
- SHFS vs ESLA Comparison
SHFS vs ESLA Comparison
Compare SHFS & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- ESLA
- Stock Information
- Founded
- SHFS 2015
- ESLA 2021
- Country
- SHFS United States
- ESLA United States
- Employees
- SHFS N/A
- ESLA N/A
- Industry
- SHFS Finance: Consumer Services
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHFS Finance
- ESLA Health Care
- Exchange
- SHFS Nasdaq
- ESLA Nasdaq
- Market Cap
- SHFS 25.6M
- ESLA 41.6M
- IPO Year
- SHFS N/A
- ESLA N/A
- Fundamental
- Price
- SHFS $0.49
- ESLA $0.82
- Analyst Decision
- SHFS
- ESLA
- Analyst Count
- SHFS 0
- ESLA 0
- Target Price
- SHFS N/A
- ESLA N/A
- AVG Volume (30 Days)
- SHFS 51.1K
- ESLA 370.5K
- Earning Date
- SHFS 11-12-2024
- ESLA 11-01-2024
- Dividend Yield
- SHFS N/A
- ESLA N/A
- EPS Growth
- SHFS N/A
- ESLA N/A
- EPS
- SHFS 0.08
- ESLA N/A
- Revenue
- SHFS $16,719,536.00
- ESLA N/A
- Revenue This Year
- SHFS N/A
- ESLA N/A
- Revenue Next Year
- SHFS N/A
- ESLA N/A
- P/E Ratio
- SHFS $5.56
- ESLA N/A
- Revenue Growth
- SHFS 34.73
- ESLA N/A
- 52 Week Low
- SHFS $0.44
- ESLA $0.77
- 52 Week High
- SHFS $1.55
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- SHFS 51.15
- ESLA 39.62
- Support Level
- SHFS $0.46
- ESLA $0.87
- Resistance Level
- SHFS $0.51
- ESLA $1.24
- Average True Range (ATR)
- SHFS 0.03
- ESLA 0.12
- MACD
- SHFS 0.00
- ESLA -0.01
- Stochastic Oscillator
- SHFS 80.61
- ESLA 12.57
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.